Exact Mass: 344.19874880000003
Exact Mass Matches: 344.19874880000003
Found 500 metabolites which its exact mass value is equals to given mass value 344.19874880000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Formoterol
Formoterol is a long-acting (12 hours) beta2-agonist used in the management of asthma and/or chronic obstructive pulmonary disease (COPD). Inhaled formoterol works like other beta2-agonists, causing bronchodilatation through relaxation of the smooth muscle in the airway so as to treat the exacerbation of asthma. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3-(2-methyl-1,3,4,5,12,12a-hexahydropyrido[3,4-b]acridin-4a-yl)phenol
C23H24N2O (344.18885339999997)
11-Dehydrocorticosterone
11-Dehydrocorticosterone is a mineral corticosteroid. The conversion of inactive 11-ketoglucocorticoids such as 11-dehydrocorticosterone) into active 11b-hydroxyglucocorticoids (such as corticosterone) is catalyzed by 11beta-hydroxysteroid dehydrogenase (11b-HSD1, EC 1.1.1.146), which is expressed in many tissues and plays an important role in metabolically relevant tissues such as the liver, adipose tissue, skeletal muscles and possibly kidney. Chronically elevated local glucocorticoid action as a result of increased 11beta-HSD1 activity rather than elevated systemic glucocorticoid levels has been associated with metabolic syndrome, which is characterized by obesity, insulin resistance, type 2 diabetes and cardiovascular complications. Recent studies indicate that compounds inhibiting 11beta-HSD1 activity ameliorate the adverse effects of excessive glucocorticoid concentrations on metabolic processes, providing promising opportunities for the development of therapeutic interventions. 11-dehydrocorticosterone and corticosterone display antinatriuretic activity, although 11-dehydrocorticosterone is generally a more potent sodium retainer than corticosterone. (PMID: 17584152, Endocr Metab Immune Disord Drug Targets. 2007 Jun;7(2):125-40.) [HMDB] 11-Dehydrocorticosterone is a mineral corticosteroid. The conversion of inactive 11-ketoglucocorticoids such as 11-dehydrocorticosterone) into active 11b-hydroxyglucocorticoids (such as corticosterone) is catalyzed by 11beta-hydroxysteroid dehydrogenase (11b-HSD1, EC 1.1.1.146), which is expressed in many tissues and plays an important role in metabolically relevant tissues such as the liver, adipose tissue, skeletal muscles and possibly kidney. Chronically elevated local glucocorticoid action as a result of increased 11beta-HSD1 activity rather than elevated systemic glucocorticoid levels has been associated with metabolic syndrome, which is characterized by obesity, insulin resistance, type 2 diabetes and cardiovascular complications. Recent studies indicate that compounds inhibiting 11beta-HSD1 activity ameliorate the adverse effects of excessive glucocorticoid concentrations on metabolic processes, providing promising opportunities for the development of therapeutic interventions. 11-dehydrocorticosterone and corticosterone display antinatriuretic activity, although 11-dehydrocorticosterone is generally a more potent sodium retainer than corticosterone. (PMID: 17584152, Endocr Metab Immune Disord Drug Targets. 2007 Jun;7(2):125-40.).
Oxyphencyclimine
C20H28N2O3 (344.20998180000004)
Oxyphencyclimine is only found in individuals that have used or taken this drug. It is an anticholinergic drug (trade name Daricon) used in treating peptic ulcers.Oxyphencyclimine binds the muscarinic acetylcholine receptor. It may block all three types of muscarinic receptors including M-1 receptors in the CNS and ganglia, M-2 receptors in the heart (vagus) and M-3 receptors at the parasympathetic NEJ system. The muscarinic acetylcholine receptors mediate various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Oxphencyclimine inhibits vagally mediated reflexes by antagonizing the action of acetylcholine. This in turn reduces the secretion of gastric acids in the stomach. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
alpha,alpha-Diethyl-4,4-bis(2-propynyloxy)stilbene
3-[(4aS,12aR)-2-methyl-1,3,4,5,12,12a-hexahydropyrido[3,4-b]acridin-4a-yl]phenol
C23H24N2O (344.18885339999997)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol
11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol, also known as delta(1)-Tetrahydrocannabinol-7-Oic acid or delta-9-11-Carboxytetrahydrocannabinol, is classified as a member of the 2,2-dimethyl-1-benzopyrans. 2,2-dimethyl-1-benzopyrans are organic compounds containing a 1-benzopyran moiety that carries two methyl groups at the 2-position. 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol is considered to be practically insoluble (in water) and acidic
(E,E)-Boviquinone 3
(E,E)-Boviquinone 3 is found in mushrooms. (E,E)-Boviquinone 3 is a pigment from Chroogomphus rutilus (pine spike cap Pigment from Chroogomphus rutilus (pine spike cap). (E,E)-Boviquinone 3 is found in mushrooms.
Neotussilagolactone
Neotussilagolactone is found in tea. Neotussilagolactone is a constituent of Tussilago farfara (coltsfoot) Constituent of Tussilago farfara (coltsfoot). Neotussilagolactone is found in tea.
Formebolone
Formebolone is a synthetic anabolic steroid. It is suspected of misuse in sports and therefore tested for in regular screening of athletes. The desire to artificially enhance physical performance in order to increase the chances to win in sports competition is supposedly as old as mankind itself. Already during the ancient Olympic Games, in approximately 200 B.C., athletes used concoctions of mushrooms and plant seeds, as well as special diets including bovine and canine testicles, as reported by Philostratos and Galen. The attempt to improve the power and strength of racing animals also has a long history, as it has been reported that the ancient Romans fed their horses so-called Hydromel, a mixture of honey and water, in order to increase endurance. The manipulation of the capacities of an athlete or animal has been referred to as doping since 1889, when this term, originating from a dialect spoken in the south-eastern region of Africa, was included in a British dictionary. With the athlete Linton, the first authentic doping-related death occurred in 1886 during a cycle race (Paris-Bordeaux), caused by an overdose of caffeine. (For a more complete review on doping see PMID: 15808003) [HMDB] Formebolone is a synthetic anabolic steroid. It is suspected of misuse in sports and therefore tested for in regular screening of athletes. The desire to artificially enhance physical performance in order to increase the chances to win in sports competition is supposedly as old as mankind itself. Already during the ancient Olympic Games, in approximately 200 B.C., athletes used concoctions of mushrooms and plant seeds, as well as special diets including bovine and canine testicles, as reported by Philostratos and Galen. The attempt to improve the power and strength of racing animals also has a long history, as it has been reported that the ancient Romans fed their horses so-called Hydromel, a mixture of honey and water, in order to increase endurance. The manipulation of the capacities of an athlete or animal has been referred to as doping since 1889, when this term, originating from a dialect spoken in the south-eastern region of Africa, was included in a British dictionary. With the athlete Linton, the first authentic doping-related death occurred in 1886 during a cycle race (Paris-Bordeaux), caused by an overdose of caffeine. (For a more complete review on doping see PMID: 15808003). C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
19-Oxo-deoxycorticosterone
19-oxo-deoxycorticosterone (19-oxo-DOC) is a steroid recently isolated from the rat adrenal gland.19-Oxo-Deoxycorticosterone Binds to the Renal Mineralocorticoid Receptor and Produces Sodium Retention but Not Potassium Excretion.19-oxo-DOC both binds to type I renal mineralocor-ticoid receptors and produces the expected antinatriuretic effect of maximal doses of mineralocorticoids. This lack of a kaliuretic effect suggests that either 1) the kaliuretic effect of steroids such as aldosterone is mediated by a binding site other than the type I receptors, or 2) that potassium secretion mediated by aldoster-one-type I receptor interactions in discrete nephron target segments can be influenced by a steroid-sensitive potassium-recycling system in a more distal nephron site. 19-hydroxydeoxycorticosterone (19,21-dihydroxy-4-pregnen-3,20-dione), 19-oxo-deoxycorticosterone (21-hydroxy-4-pregnen-3,19,20-trione), and 19-oic-deoxycorticosterone (19-oic-21-hydroxy-4-pregnen-3,20-dione)are formed from precursor deoxycorticosterone by adrenal glands obtained from intact rats and from rats undergoing adrenal regeneration.rat adrenals have the enzymes required to convert deoxycorticosterone to 19-hydroxydeoxycorticosterone, 19-oxo-deoxycorticosterone, and 19-oic-deoxycorticosterone; however, rat adrenals do not convert deoxycorticosterone or any of the oxygenated metabolites to 19-nor-deoxycorticosterone (21-hydroxy-19-nor-4-pregnen-3,20-dione). It is possible, however, that 19-nor-deoxycorticosterone is formed at peripheral sites from the oxygenated deoxycorticosterone precursors. 19-oxo-deoxycorticosterone (19-oxo-DOC) is a steroid recently isolated from the rat adrenal gland.19-Oxo-Deoxycorticosterone Binds to the Renal Mineralocorticoid Receptor and Produces Sodium Retention but Not Potassium Excretion.19-oxo-DOC both binds to type I renal mineralocor-ticoid receptors and produces the expected antinatriuretic effect of maximal doses of mineralocorticoids. This lack of a kaliuretic effect suggests that either 1) the kaliuretic effect of steroids such as aldosterone is mediated by a binding site other than the type I receptors, or 2) that potassium secretion mediated by aldoster-one-type I receptor interactions in discrete nephron target segments can be influenced by a steroid-sensitive potassium-recycling system in a more distal nephron site
Arformoterol
Arformoterol is a bronchodilator. It works by relaxing muscles in the airways to improve breathing. Arformoterol inhalation is used to prevent bronchoconstriction in people with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. The use of arformoterol is pending revision due to safety concerns in regards to an increased risk of severe exacerbation of asthma symptoms, leading to hospitalization as well as death in some patients using long acting beta agonists for the treatment of asthma. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents COVID info from clinicaltrials, clinicaltrial Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(6Ar,10ar)-1-hydroxy-6,6-dimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6h-benzo[c]chromene-9-carboxylic acid
7-Oxodehydroepiandrosterone 3-acetate
21-Deoxycortisone
4-Acetoxy-4-androstene-3,17-dione
[(8S,9S,13S,14S,17R)-3,17-Dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-1-yl] propanoate
15,16-Epoxy-20-oxo-8(17),13(16),14-labdatrien-19-oic acid methyl ester
[4S-[4alpha(E),4aalpha,5alpha,8abeta]]-4,4a,5,6,7,8,8a,9-Octahydro-3,4a,5-trimethyl-9-oxonaphtho[2,3-b]furan-4-yl ester 3-methyl-2-pentenoic acid
12-Methyl-5-dehydrohorminone
An abietane diterpenoid that is 5-dehydrohorminone in which the hydroxy group at position 12 is replaced by a methoxy group. Isolated from the roots of Salvia multicaulis, it exhibits antitubercular activity.
6,12-dihydroxy-11-methoxyabieta-5,8,11,13-tetraen-7-one
3beta-acetoxy-12-methoxy-13-methyl-podocarpa-8,11,13-trien-7-one|3beta-acetoxy-12-methoxy-13-methyl-podocarpane-8,11,13-trien-7-one|3beta-acetoxy-12-methoxy-13-methylpodocarpa-8,11,13-trien-7-one|3??-Acetoxy-12-methoxy-13-methyl-podocarpa-8,11,13-trien-7-one.
(4R,9R)-10-hydroxy-13-methoxy-9-methyl-15-oxo-20-norkaur-16-en-18-oic acid gamma-lactone
2,11beta-Dimethoxy-3-hydoxo-D-homoestra-1,3,5(10)trien-17a-on
(2E)-1,4-diacetoxy-2-(3,7-dimethylocta-2,6-dienyl)-6-methylbenzene
6beta-hydroxy-3beta-<4-methylsenecioyloxy>-euryopsin
Methyl 15,16-epoxy-12-oxo-8(17),13(16),14-ent-labdatrien-19-oate
15-desmethoxy-16-oxo-15,16H-seco-nidoresedic acid methyl ester|15-desmethoxy-16-oxo-15,16H-strictic acid methyl ester|methyl ester of 16-oxo-15,16H-strictic acid
10,11-dimethoxy-17-nor-corynan-16-ol|Ochropposinin
C20H28N2O3 (344.20998180000004)
5alpha-Hydroxyconyscabrasaeure-methylester|methyl 5alpha-hydroxyconyscabroate
4beta-hydroxy-5beta,6beta-epoxypregn-2-ene-1,20-dione
(6aR,8R,9aR)-8-methoxy-6a-methyl-8-pentyl-3-((E)-prop-1-enyl)-6a,8,9,9atetrahydro-6H-furo[2,3-h]-isochromen-6-one|monapurone C
12-methylcoleon U|6,11-dihydro-12-methoxy-5,8,11,13-abietatetraen-7-one
Acetamide, N,N-[[(2S,5S)-3,6-dioxo-2,5-piperazinediyl]di-3,1-propanediyl]bis[N-hydroxy-
16-methoxy-6-oxo-7,11,13-labdatrien-16,15-olide|spicatanol methyl ether
5alpha-hydroxy-1,2-dehydro-5,10-dihydroprintzianic acid methyl ester|5alpha-Hydroxy-1,2-dehydro-5,10-dihydroprintziasaeure-methylester
4a.alpha.,4b.beta.-Gibbane-1.alpha.,10.beta.-dicarboxylic acid, 4a-(hydroxymethyl)-1-methyl-8-methylene-, 1,4a-lactone, methyl ester
8beta-hydroxy-14(17)-ene-18alpha-methoxycarbonyl-18-norvouacapene|mimosol A
15-oxo-14,16H-seco-nidoresedic acid methyl ester|15-oxo-14,16H-strictic acid methyl ester
3,5,5-trimethyl-4-(2-beta-D-glucopyranosyloxy)ethyl-cyclohexa-2-en-1-one
methyl 14beta-hydroxy-12-oxo-3,4-secopimara-7,9(11),13,15,19(4)-tetraen-3-oate|trigonoheterene
7beta-methoxy-8,11,13-triene-18,6alpha-abietanolide|liquidambolide A
15beta,17alpha-dihydroxypregna-4,6-diene-3,20-dione
4-O-[6,7-dihydro-5,6E-dehydro-7(9)-dehydrogeranyl]-sinapyl alcohol
4-O-geranyl-sinapyl aldehyde|4-O-geranylsinapyl aldehyde|geranyloxy sinapyl aldehyde|Nelumal A
5-methoxy-11.14-dioxo-abiata-8,12,15-triene|bractealine
13-dehydroxysarcoglaucol-16-one|2,5,6,9,10,13,14,16-octahydro-4,12,15-trimethyl-16-oxocyclotetradeca[b]furan-8-carboxylic acid methyl ester
Triptonoditerpenic acid
(E,E)-1,11-bis(furan-3-yl)-4,8-dimethylundeca-7,10-diene-4,6-diol|Untenospongin A
formoterol
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
RHODOTORULIC ACID
A member of the class of 2,5-diketopiperazines obtained by cyclodimerisation of N(5)-acetyl-N(5)-hydroxy-L-ornithine.
Ala Ala Ala Ile
Ala Ala Ala Leu
Ala Ala Ile Ala
Ala Ala Leu Ala
Ala Ala Pro Ser
Ala Ala Ser Pro
Ala Gly Pro Thr
Ala Gly Thr Pro
Ala Gly Val Val
Ala Ile Ala Ala
Ala Leu Ala Ala
Ala Pro Ala Ser
Ala Pro Gly Thr
Ala Pro Ser Ala
Ala Pro Thr Gly
Ala Ser Ala Pro
Ala Ser Pro Ala
Ala Thr Gly Pro
Ala Thr Pro Gly
Ala Val Gly Val
Ala Val Val Gly
Gly Ala Pro Thr
Gly Ala Thr Pro
Gly Ala Val Val
Gly Gly Ile Val
Gly Gly Leu Val
Gly Gly Val Ile
Gly Gly Val Leu
Gly Ile Gly Val
Gly Ile Val Gly
Gly Leu Gly Val
Gly Leu Val Gly
Gly Pro Ala Thr
Gly Pro Thr Ala
Gly Thr Ala Pro
Gly Thr Pro Ala
Gly Val Ala Val
Gly Val Gly Ile
Gly Val Gly Leu
Gly Val Ile Gly
Gly Val Leu Gly
Gly Val Val Ala
Ile Ala Ala Ala
Ile Gly Gly Val
Ile Gly Val Gly
Ile Val Gly Gly
Leu Ala Ala Ala
Leu Gly Gly Val
Leu Gly Val Gly
Leu Val Gly Gly
Pro Ala Ala Ser
Pro Ala Gly Thr
Pro Ala Ser Ala
Pro Ala Thr Gly
Pro Gly Ala Thr
Pro Gly Thr Ala
Pro Ser Ala Ala
Pro Thr Ala Gly
Pro Thr Gly Ala
Ser Ala Ala Pro
Ser Ala Pro Ala
Ser Pro Ala Ala
Thr Ala Gly Pro
Thr Ala Pro Gly
Thr Gly Ala Pro
Thr Gly Pro Ala
Thr Pro Ala Gly
Thr Pro Gly Ala
Val Ala Gly Val
Val Ala Val Gly
Val Gly Ala Val
Val Gly Gly Ile
Val Gly Gly Leu
Val Gly Ile Gly
Val Gly Leu Gly
Val Gly Val Ala
Val Ile Gly Gly
Val Leu Gly Gly
Val Val Ala Gly
Val Val Gly Ala
4-[4-(3,4-Dimethoxyphenyl)-2,3-dimethylbutyl]-2-methoxyphenol
11-DEHYDROCORTICOSTERONE
An 11-oxo steroid that is corticosterone in which the hydroxy substituent at the 11beta position has been oxidised to give the corresponding ketone. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Methyl α-Linolenyl Fluorophosphonate
Methyl γ-Linolenyl Fluorophosphonate
Arformoterol
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents COVID info from clinicaltrials, clinicaltrial Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(E,E)-Boviquinone 3
Neotussilagolactone
FA 18:2;O4
ascr#19
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,11R)-11-hydroxydodec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#19
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-12-hydroxydodec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
Formebolone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
ST 21:4;O4
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
benoxinate hydrochloride
C17H29ClN2O3 (344.18665940000005)
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
1-BOC-3-(4-TRIFLUOROMETHYL-PHENYLAMINO)-PIPERIDINE
1-BOC-3-(3-TRIFLUOROMETHYL-PHENYLAMINO)-PIPERIDINE
[1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-5-(1-piperidinyl)-1H-indo l-2-yl]boronic acid
C18H25BN2O4 (344.19072800000004)
4-[1-hydroxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]benzene-1,2-diol
tert-butyl 9-benzyl-10-oxo-1,9-diazaspiro[4.5]decane-1-carboxylate
C20H28N2O3 (344.20998180000004)
4-tert-butoxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester
2,2-dimethyl-1-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridin-1-yl]propan-1-one
1-BOC-3-([(2-TRIFLUOROMETHYL-PHENYL)-AMINO]-METHYL)-PYRROLIDINE
1-BOC-3-([(3-TRIFLUOROMETHYL-PHENYL)-AMINO]-METHYL)-PYRROLIDINE
1-BOC-3-([(4-TRIFLUOROMETHYL-PHENYL)-AMINO]-METHYL)-PYRROLIDINE
tert-butyl 4-[4-(trifluoromethyl)anilino]piperidine-1-carboxylate
tolamolol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
1-{2-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL}-2-METHYL-5-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID
tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-b]pyridine-1-carboxylate
C18H25BN2O4 (344.19072800000004)
tert-butyl 4-(3-ethyl-2-oxo-3H-indol-1-yl)piperidine-1-carboxylate
C20H28N2O3 (344.20998180000004)
2-methyl-4-[(2-propoxybenzoyl)amino]-5-propylpyrazole-3-carboxamide
L-LYSYL-D-PROLYL-L-THREONINE
Lys-D-Pro-Thr, an IL-1beta analogue, is a potent IL-1 inhibitor. Lys-D-Pro-Thr inhibits the protective effects of IL-1 beta[1][2].
1H-PYRIDO[3,4-B]INDOLE-1-ACETIC ACID, 2-[(1,1-DIMETHYLETHOXY)CARBONYL]-2,3,4,9-TETRAHYDRO-, METHYL ESTER
2-Methyl-2-propanyl 2-benzyl-3-oxo-2,8-diazaspiro[4.5]decane-8-ca rboxylate
C20H28N2O3 (344.20998180000004)
1-Boc-indazole-5-boronic acid pinacol ester
C18H25BN2O4 (344.19072800000004)
1-boc-4-[(2-cyano-ethyl)-pyridin-3-ylmethyl-amino]-piperidine
(S)-1,4-Di-tert-butyl 2-methyl piperazine-1,2,4-tricarboxylate
(R)-1,4-di-Boc-piperazine-2-carboxylic acid Methyl ester
1-(4-methyl-1-piperazinyl)-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-Ethanone
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclopentyl-N-(2-methylpropyl)- (9CI)
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclohexyl-N-propyl- (9CI)
tert-butyl 3-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate
C18H25BN2O4 (344.19072800000004)
1-[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methanamine
N-HEXADECYLSULFURIC ACID SODIUM SALT
C16H33NaO4S (344.19971380000004)
Sodium 2-[methyl(1-oxododecyl)amino]ethanesulphonate
1,4-DI-TERT-BUTYL 2-METHYL PIPERAZINE-1,2,4-TRICARBOXYLATE
Anecortave
S - Sensory organs > S01 - Ophthalmologicals > S01L - Ocular vascular disorder agents > S01LA - Antineovascularisation agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors
Mivavotinib
C17H21FN6O (344.17607879999997)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(S,S)-Formoterol
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents COVID info from clinicaltrials, clinicaltrial Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Triptobenzene H
An abietane diterpenoid with formula C21H28O4, originally isolated from Tripterygium wilfordii.
(2E,11R)-11-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodec-2-enoic acid
(2E)-12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodec-2-enoic acid
4-Amino-3-butoxybenzoic acid 2-(diethylamino)ethyl ester hydrochloride
C17H29ClN2O3 (344.18665940000005)
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents
Estradiol 3-(trimethylsilyl) ether
C21H32O2Si (344.21714519999995)
Camphoric acid bis(trimethylsilyl) ester
C16H32O4Si2 (344.18390320000003)
N-(4-Carbamimidoylbenzyl)-1-(4-Methylpentanoyl)-L-Prolinamide
(S)-laudanine(1+)
C20H26NO4+ (344.1861736000001)
The (S)-enantiomer of laudanine(1+).
(S)-codamine(1+)
C20H26NO4+ (344.1861736000001)
An ammonium ion derivative resulting from the protonation of the amino group of (S)-codamine. The major species at pH 7.3.
L-Lys-3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-OH
(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoic acid
[(8S,9S,13S,14S,17R)-3,17-Dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-1-yl] propanoate
[3-carboxy-2-[(E)-9-carboxynon-6-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-9-carboxynon-5-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-9-carboxynon-2-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-9-carboxynon-7-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-9-carboxynon-4-enoyl]oxypropyl]-trimethylazanium
4-[(2S,3R)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-2-methoxyphenol
N-cyclohexyl-1-hydroxy-5-nitro-4-spiro[benzimidazole-2,1-cyclohexane]imine
4-(1-azepanyl)-6-hydrazinyl-N-(4-nitrophenyl)-1,3,5-triazin-2-amine
1-[1-(4-Butan-2-ylphenyl)ethyl]-3-[(4-fluorophenyl)methyl]thiourea
1-[(4-Fluorophenyl)methyl]-3-[1-(4-propan-2-ylphenyl)propyl]thiourea
7-Hydroxy-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium
C20H26NO4+ (344.1861736000001)
19-Oxo-deoxycorticosterone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Laudanine(1+)
C20H26NO4+ (344.1861736000001)
An organic cation that is the conjugate acid of laudanine, obtained by protonation of the tertiary amino group.
[2-(3,4-Dimethylphenyl)-4-quinolinyl]-(1-piperidinyl)methanone
C23H24N2O (344.18885339999997)
Cyclohexanecarboxylic acid [2-oxo-2-[4-(1-piperidinyl)anilino]ethyl] ester
C20H28N2O3 (344.20998180000004)
1-(tert-butyl)-4-[({[(4-methoxyanilino)carbonyl]oxy}imino)methyl]-3,5-dimethyl-1H-pyrazole
(6aR)-1-hydroxy-6,6-dimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c][1]benzopyran-9-carboxylic acid
Diethyl (3-ethyl-1-ethoxy-2-oxoheptyl)propanedioate
2-Hydroxy-5-[1-hydroxy-2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzamide
6-De(cyclopropylamino)-6-(3-cyclopropyl-3-fluoroazetidin-1-yl)abacavir
C17H21FN6O (344.17607879999997)
6-De(cyclopropylamino)-6-(3-isopropoxyazetidin-1-yl)abacavir
C17H24N6O2 (344.19606439999995)
2,3-Dihydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide
4-Ethoxycarbonyl-6-ethyl-5-methyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-trans-6,6A-cis)
4-Ethoxycarbonyl-6-ethyl-5-methyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-cis-6,6A-trans)
oxyphencyclimine
C20H28N2O3 (344.20998180000004)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
3-[(4Ar,12aS)-2-methyl-1,3,4,5,12,12a-hexahydropyrido[3,4-b]acridin-4a-yl]phenol
C23H24N2O (344.18885339999997)
(R)-tetrahydropapaverine(1+)
An organic cation that is the conjugate acid of (R)-tetrahydropapaverine, obtained by protonation of the secondary amino group; major species at pH 7.3.
11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol
A phytocannabinoid that is Delta(9)-tetrahydrocannabinol in which the C-11 methyl has been fully oxidised to a carboxy group. Further enzymatic oxidation product of 11-hydroxy-Delta(9)-tetrahydrocannabinol.
21-deoxycortisone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(E)-8-(5-(1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)octanoic acid
(E)-12-(5-ethyl-4-hydroxytetrahydrofuran-2-yl)-9,12-dihydroxydodec-10-enoic acid
(E)-9-hydroxy-11-(3-hydroxy-5-(1-hydroxypropyl)tetrahydrofuran-2-yl)undec-10-enoic acid
(E)-9-hydroxy-9-(4-hydroxy-5-(3-hydroxypent-1-en-1-yl)tetrahydrofuran-2-yl)nonanoic acid
(-)-(8R,8S)-3,3,4-trimethoxy-4-hydroxylignan
A lignan that is 2,3-dimethylbutane substituted by a 4-hydroxy-3-methoxyphenyl group at position 1 and a 3,4-dimethoxyphenyl group at position 4. It has been isolated from the bark of Machilus robusta.
(S)-tembetarine
A tembetarine obtained by methylation of the tertiary amino function of (R)-reticuline.